DBS in Parkinson’s:
Beyond the Myths – Who to Refer and When
Thursday, December 10 | 18:00 – 19:30 CET
Your browser is out of date
With an updated browser, you will have a better Medtronic web site experience. Update my browser now.
When is the right time to consider DBS for a patient with Parkinson’s disease?
Join our expert faculty for an interactive webinar challenging common misconceptions around DBS and exploring the factors that can help identify the right patient at the right time.
Through real-world patient scenarios, audience voting and expert discussion, you’ll gain practical insights to support confident and timely DBS decision-making.
Prof. Francesca Morgante
St. George’s Hospital, United Kingdom
Dr. Okeanis Vaou
UT Health San Antonio, United States
Moderator: Dr. Ash Sharan
Chief Medical Officer
Medtronic Neuromodulation
This material should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s). Please note that the intended use of a product may vary depending on geographical approvals.
See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.
For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI. If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com.
Manuals can be viewed using a current version of any major internet browser.
For best results, use Adobe Acrobat® Reader with the browser. Medtronic products placed on European markets comply with EU and UK legislation (if applicable) on medical devices. For any further information, contact your local Medtronic representative and/or consult Medtronic’s websites.
2026-dbs-referral-registration-webpage-en-gb-emea-21643875